Merck Argues Investors Can’t Sue over Vioxx Drug

Merck and Co., the makers of Vioxx argued in court this week that investors can’t sue them for the defunct product because the statute of limitation is over for a defective drug lawsuit.  Vioxx, which was pulled off the market because it doubled the risks of heart attack, stroke and death cost the company and [...]